The latest news

Jan 11, 2023

Demystifying AI's role in healthcare to reassure new providers – and old pros

Dec 28, 2022

NeurologyLive® Year in Review 2022: Most-Watched Movement Disorder Expert Interviews

Dec 27, 2022

Fujifilm Signs Agreement to Acquire Digital Pathology Technology Assets

Dec 27, 2022

FDA-Approved Advanced Lung Cancer CDx, Thermo Fisher’s Rapid Infectious Microbe Detection Panel, More

Dec 22, 2022

The rise of health system-based innovation centers

Dec 21, 2022

Development and Validation of an AI-Enabled Digital Breast Cancer Assay to Predict Early-Stage Breast Cancer Recurrence Within 6 Years

Dec 8, 2022

Predictions Series 2022: AiThority Interview with Dr. Jack Zeineh, Co-Founder and CTO at PreciseDx

Dec 6, 2022

Netherlands laboratory launches AI study for breast cancer diagnosis

Dec 1, 2022

PreciseDx Announces New Collaboration with Laboratory of Pathology at Dordrecht Albert Schweitzer Hospital

Nov 30, 2022

PreciseDx collaborates with the Laboratory of Pathology in Dordrecht